Sun Pharmaceutical Industries Ltd

NSE: SUNPHARMA · BSE: 524715 · Pharmaceuticals & Biotechnology · 16 announcements

Share price: ₹1,852.20
Market cap: ₹4,44,405 Cr
Revenue (annual): ₹58,462 Cr
Net profit (annual): ₹11,479 Cr
P/E (TTM): 36.7×Sector 50.4×
Promoter holding: 54.48%+0.00% QoQ
FII holding: 14.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 9 Financial Results 3 Promoter Reclassification 1 Merger & Restructuring 1 Legal & Regulatory 1 Credit Rating 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

9 Sep 2026 14:58 IST BSE

Merger & Restructuring

Sun Pharmaceutical Industries Merger & Restructuring Worth ₹9.5 Cr

Sun Pharma incorporates a new treasury subsidiary in GIFT City, Gandhinagar. Initial equity subscription is approximately ₹9.50 Crore for group treasury operations.

Value: ₹9.50 Cr

Read the filing ↗